Newspaper from Sancti Spiritus, Cuba

Spanish . RSS  . Site Map
Escambray on Facebook Escambray on Twitter Escambray on Flickr RSS Feed

HEBERPROT-P

Cuba, Russia Discuss Increasing Public Health Cooperation

The next meeting of the Russia-Cuba Health Working Group Intergovernmental Commission will be held in May


Cuba’s Heberprot-P Granted Health Registration in 23 Countries

Unique in the world to treat advanced foot ulcers in diabetic patients, the Cuban drug Heberprot-P has already been registered in 23 countries, it was informed today


Cuba Hosts Congress on Diabetes

Specialists from at least 40 countries will assist to the International Congress “Controlling diabetes and its most severe complications”, to take place December 10th to 12th, in Varadero.  


Over 31,000 Cuban Patients Benefit from Heberprot-P

Cuba reduced by over 78 percent the relative risk of amputation due to diabetic foot ulcers, thanks to a comprehensive program of care for these patients that includes the use of the drug Heberprot-P.


Cuban Biotechnology Industry Acknowledged in Russia

Russia’s Health Minister Veronika Skortsova stressed in Moscow the quality of the Cuban biotechnology industry and expressed her interest in having a larger presence of Cuban pharmaceuticals in her country.


Belarus Diabetic Patients to Cure with Cuban Heberprot-P

Belarus will apply Cuban unique drug worldwide to heal diabetic foot Heberprot-P, according to an agreement signed here, highlighted the Belarusian media.


Sancti Spiritus Outstanding in Heberprot-P Treatment Actions

Heberprot-P is a unique drug developed in Cuba.


Ecuadorians Benefit with Cuban Heberprot-p

The Cuban product Heberprot-p, to cure complaints resulting from diabetes, is welcomed in Ecuador for the results reported by patients with treatment in this South American country.


More than 300 People in Sancti Spiritus Treated with Heberprot-p

Introduced five years ago Heberprot-p, the Cuban drug to treat diabetic foot ulcers, has proven effectiveness: after its application the rates of amputations in patients suffering from this disease have decreased.


Cuba’s Heberprot-P Benefits over 60,000 Patients in the World

Heberprot-P, the only product in the world capable of curing  diabetic foot ulcers, has benefited over 60,000 people in the world since its registration in  Cuba in 2006, announced an expert.


Next page »